Sodium-glucose cotransporter 2 inhibitors and cardiovascular events among patients with type 2 diabetes and low-to-normal body mass index: a nationwide cohort study.

导出 OA

翻译打印收藏纠错

作者： Yuichiro,Mori ^[1] ; Toshiaki,Komura ^[2] ; Motohiko,Adomi ^[3] ; Ryuichiro,Yagi ^[4] ; Shingo,Fukuma ^[1] ; Naoki,Kondo ^[5] ; Motoko,Yanagita ^[6] ; O Kenrik,Duru ^[7] ; Katherine R,Tuttle ^[8] ; Kosuke,Inoue ^[9]

作者单位： Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan. ^[1] Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA. ^[2] Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. ^[3] Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.;Harvard Medical School, Boston, MA, USA. ^[4] Department of Social Epidemiology, Graduate School of Medicine, Kyoto University, Yoshida-Konoecho, Sakyo-Ku, Kyoto-Shi, Kyoto, 6068315, Japan. ^[5] Department of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.;Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan. ^[6] Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. ^[7] Kidney Research Institute, University of Washington, Seattle, WA, USA.;Division of Nephrology, University of Washington, Seattle, WA, USA.;Providence Medical Research Center, Providence Inland Northwest Health, Spokane, WA, USA. ^[8] Department of Social Epidemiology, Graduate School of Medicine, Kyoto University, Yoshida-Konoecho, Sakyo-Ku, Kyoto-Shi, Kyoto, 6068315, Japan. inoue.kosuke.2j@kyoto-u.ac.jp.;Hakubi Center for Advanced Research, Kyoto University, Kyoto, Japan. inoue.kosuke.2j@kyoto-u.ac.jp. ^[9]